Funds holding ALX Oncology Holdings Inc
ISIN US00166B1052 · United States
- Fund holders
- 17
- Of which ETFs
- 3 14 other funds
- Value held
- 9.6M $
- Share of capital
- 3.4 % of 138.3M shares on Jul 30, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 3,642,854 | 7.3M $ | 0.00 % | 2.63 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 400,719 | 803.4K $ | 0.00 % | 0.29 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 189,414 | 399.7K $ | 0.00 % | 0.14 % | as of Feb 28, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 98,277 | 207.4K $ | 0.00 % | 0.07 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 77,665 | 163.9K $ | 0.00 % | 0.06 % | as of Feb 28, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 72,511 | 145.4K $ | 0.00 % | 0.05 % | as of Mar 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 63,652 | 127.6K $ | 0.00 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 61,000 | 122.3K $ | 0.10 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 49,321 | 104.1K $ | 0.00 % | 0.04 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 26,897 | 56.8K $ | 0.00 % | 0.02 % | as of Feb 28, 2026 ↗ |
| Small Cap Core Fund Northern Funds | 17,558 | 35.2K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Ultra-Small Company Fund Bridgeway Funds, Inc. | 15,072 | 30.2K $ | 0.04 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 10,900 | 21.9K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 10,877 | 18.5K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Diversified Equity Master Portfolio Master Investment Portfolio | 4,859 | 9.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Small Cap Equity ETF American Century ETF Trust | 4,191 | 8.8K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 1,632 | 3.4K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.10 % | as of Mar 31, 2026 ↗ |
| Ultra-Small Company Fund Bridgeway Funds, Inc. | 0.04 % | as of Mar 31, 2026 ↗ |
| Small Cap Core Fund Northern Funds | 0.01 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 0.00 % | as of Feb 28, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 0.00 % | as of Mar 31, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 0.00 % | as of Apr 30, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 17 | +3 | 4,747,399 | +159.6 % |
| 2026Q1 | 14 | +1 | 1,828,847 | +2.3 % |
| 2025Q4 | 13 | -26 | 1,787,814 | -35.7 % |
| 2025Q3 | 39 | -42 | 2,781,725 | -40.7 % |
| 2025Q2 | 81 | -16 | 4,690,723 | -2.8 % |
| 2025Q1 | 97 | -20 | 4,823,708 | -41.4 % |
| 2024Q4 | 117 | -20 | 8,230,271 | -32.0 % |
| 2024Q3 | 137 | 0 | 12,102,164 | +1.8 % |
| 2024Q2 | 137 | +8 | 11,889,880 | +2.3 % |
| 2024Q1 | 129 | 0 | 11,623,187 | +8.1 % |
| 2023Q4 | 129 | 10,750,812 |
Institutional managers
65 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 13,011,849 | 26.1M $ | as of Mar 31, 2026 |
| TCG Crossover Management, LLC | 13,011,849 | 26.1M $ | as of Mar 31, 2026 |
| venBio Partners LLC | 12,884,638 | 25.8M $ | as of Mar 31, 2026 |
| Redmile Group, LLC | 7,964,188 | 16M $ | as of Mar 31, 2026 |
| Blackstone Inc. | 5,826,544 | 11.7M $ | as of Mar 31, 2026 |
| Driehaus Capital Management LLC | 5,734,620 | 11.5M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 3,757,216 | 7.5M $ | as of Mar 31, 2026 |
| Vivo Capital, LLC | 3,184,713 | 6.4M $ | as of Mar 31, 2026 |
| Almitas Capital LLC | 3,173,834 | 6.4M $ | as of Mar 31, 2026 |
| 5AM Venture Management, LLC | 3,057,325 | 6.1M $ | as of Mar 31, 2026 |
| ORBIMED ADVISORS LLC | 2,866,256 | 5.7M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,000,000 | 4M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,988,559 | 4M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 1,587,833 | 3.2M $ | as of Mar 31, 2026 |
| Squadron Capital Management LLC | 1,460,000 | 2.9M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1,328,907 | 2.7M $ | as of Mar 31, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | 1,101,025 | 2.2K $ | as of Mar 31, 2026 |
| Ensign Peak Advisors, Inc | 950,550 | 1.9M $ | as of Mar 31, 2026 |
| UBS Group AG | 914,754 | 1.8M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 732,599 | 1.5M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 577,783 | 1.2M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 493,437 | 989.8K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 447,799 | 897.8K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 175,828 | 352.5K $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 138,593 | 277.9K $ | as of Mar 31, 2026 |
Declared shareholders of ALX Oncology Holdings Inc
There are 4 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Redmile Group, LLC and 2 others | 6.80 % | 9,214,188 | as of Mar 31, 2026 · SCHEDULE 13G |
| HBM Healthcare Investments (Cayman) Ltd. | 6.50 % | 8,590,692 | as of Mar 31, 2026 · SCHEDULE 13G |
| LSV Associates, LLC and 8 others | 2.20 % | 2,942,525 | as of May 27, 2026 · SCHEDULE 13D |
| Integrated Core Strategies (US) LLC and 3 others | 1.50 % | 1,988,559 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding ALX Oncology Holdings Inc". https://titelia.com/en/stocks/alx-oncology-holdings-inc-US00166B1052